Azalonum

Azalonum combines Cinnarizine and Dimenhydrinate for oral use, offering relief from motion sickness and vertigo. This medication is manufactured by Medochemie Ltd. in the EU.

Azalonum is commonly used to alleviate symptoms of motion sickness, such as nausea and dizziness. It may also help manage vertigo and other balance-related issues. The combination of Cinnarizine and Dimenhydrinate works to stabilize inner ear function and reduce discomfort associated with movement.

Users of Azalonum may experience reduced nausea and dizziness, making it easier to tolerate motion. Some individuals might feel more stable and less prone to vertigo episodes. However, effects can vary based on individual responses.

Azalonum should be handled with care, especially by those with known allergies to its components. It is advisable to consult a healthcare provider before use, particularly for individuals with underlying health conditions. Always follow the prescribed guidelines for safe administration.

Azalonum may interact with alcohol and certain medications, potentially enhancing sedative effects. It is important to avoid alcohol while using this medication. Additionally, consult a healthcare provider about other medications you are taking to prevent adverse interactions.